-
Mashup Score: 0States Aim to Combat Private-Equity Healthcare Takeovers - 13 day(s) ago
More than a dozen states are pushing back against private-equity-backed consolidation of medical businesses.
Source: www.wsj.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Open Release of Grok-1 - 1 month(s) ago
We are releasing the weights and architecture of our 314 billion parameter Mixture-of-Experts model Grok-1.
Source: x.aiCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Open Release of Grok-1 - 1 month(s) ago
We are releasing the weights and architecture of our 314 billion parameter Mixture-of-Experts model Grok-1.
Source: x.aiCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0A Bat Infestation, Postponed Surgeries and Unpaid Bills: A Hospital Chain in Crisis - 1 month(s) ago
Steward Health Care had gone on a dealmaking spree involving a big hospital landlord and a private-equity firm.
Source: www.wsj.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Open Release of Grok-1 - 1 month(s) ago
We are releasing the weights and architecture of our 314 billion parameter Mixture-of-Experts model Grok-1.
Source: x.aiCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5
This talk covers several ways to make clinical trials more efficient and to reduce the chance of ending with an equivocal result. Some of the approaches cove…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Why America's hospitals are on life support - 2 month(s) ago
Inside the financial scheme that’s crippling America’s healthcare providers
Source: www.businessinsider.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Decisions regarding the rationing of chemotherapy are commonplace in many countries around the world—including those where patients must pay for chemotherapy out of pocket—and increasingly so in cancer settings that treat both well-off and socioeconomically disadvantaged patients. However, these limitations remain jarring to oncologists and patients with cancer in the United States. Herewith, we describe some of the reasons for these drug shortages and why the situation is unlikely to change anytime
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4
Decisions regarding the rationing of chemotherapy are commonplace in many countries around the world—including those where patients must pay for chemotherapy out of pocket—and increasingly so in cancer settings that treat both well-off and socioeconomically disadvantaged patients. However, these limitations remain jarring to oncologists and patients with cancer in the United States. Herewith, we describe some of the reasons for these drug shortages and why the situation is unlikely to change anytime
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Decisions regarding the rationing of chemotherapy are commonplace in many countries around the world—including those where patients must pay for chemotherapy out of pocket—and increasingly so in cancer settings that treat both well-off and socioeconomically disadvantaged patients. However, these limitations remain jarring to oncologists and patients with cancer in the United States. Herewith, we describe some of the reasons for these drug shortages and why the situation is unlikely to change anytime
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
State lawmakers are debating and passing bills to make it harder for private-equity firms to buy up healthcare businesses across much of the U.S. https://t.co/FhD6SeBGlq via @WSJ